NDC 11695-4863 - Atropine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11695-4863
- Package NDCs from labels
- 11695-4863-1
- Manufacturer
- Covetrus North America
- Effective date
- 2019-11-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Atropine Sulfate - Covetrus North America | Covetrus North America | 2019-11-22 | PRESCRIPTION ANIMAL DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| atropine sulfate | ATROPINE SULFATE | Alcon Laboratories, Inc. | c8093125-ed1a-4eb6-9c81-52c5c7376481 | 2026-03-13 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Liver Tonic II | BOLDO, CARDUUS MARIANUS, CURCUMA LONGA, ECHINACEA (ANGUSTIFOLIA), TARAXACUM OFFICINALE MAGNESIA PHOSPHORICA, GALLBLADDER (BOVINE), HEPAR BOVINE, AMMI VISNAGA, ATROPINUM SULPHURICUM, CHELIDONIUM MAJUS, LEPTANDRA VIRGINICA, PODOPHYLLINUM | BioActive Nutritional, Inc. | b3bdb177-e2d7-4fd6-b0b7-8174fc53fb6c | 2026-03-11 | Warnings | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Apotex Corp. | 127a7e32-a150-01d6-a66a-b7708d85809f | 2026-03-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Lomotil | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Pfizer Laboratories Div Pfizer Inc | f170584a-1072-4fd7-b1dc-6756703483b9 | 2026-02-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Mylan Pharmaceuticals Inc. | 83bcc2fb-6fb0-4f0e-8e66-592d327684ec | 2026-02-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | A-S Medication Solutions | 739f384f-1a69-4953-93a0-aa6a76de0ecc | 2026-02-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| ATROPINE | ATROPINE SULFATE | A-S Medication Solutions | b4736dbc-b7c8-4b33-b7a8-a47c5654a127 | 2026-02-10 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Bausch & Lomb Americas Inc. | e294ce2b-6bb5-4f84-8a6d-ce2402ed926d | 2026-02-07 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Hepaticol Drops 5008 | HEPATICOL DROPS | Professional Complementary Health Formulas | 79ee9e37-7853-4560-a87d-cdaefb603bbb | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Renal Drops 5024 | RENAL DROPS | Professional Complementary Health Formulas | e598ae46-3b14-4dce-b7e0-abf159d102db | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Adrenal Drops 5001 | ADRENAL DROPS | Professional Complementary Health Formulas | 9c120843-c43b-4a60-8eaa-d3a951e32ee4 | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Magnesium Combination 9232 | MAGNESIUM COMBINATION | Professional Complementary Health Formulas | 4d99b3ec-724f-4385-ae5e-83389bb0c8fe | 2026-01-08 | Warnings | 03J5ZE7KA5 |
| Atropine | ATROPINE SULFATE | Redpharm Drug | 46e98d0b-3a04-7feb-e063-6394a90ac75e | 2025-12-27 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | Redpharm Drug | 301ea0f4-a1dc-ad4f-e063-6294a90acc1c | 2025-12-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE INJECTION | Medefil, Inc. | fbfdf718-befe-ad22-e053-6294a90a3715 | 2025-12-23 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ANI Pharmaceuticals, Inc. | 73dc5f91-d562-44c5-a556-66c96ed1dd82 | 2025-12-22 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 38404931-980b-0019-e063-6394a90a933f | 2025-12-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| Atropine Sulfate | ATROPINE SULFATE | ProPharma Distribution | 3d5c747f-3bf7-2597-e063-6394a90a828c | 2025-12-18 | Warnings, Adverse reactions | 03J5ZE7KA5 |
| GB-Tone | AMMI VIS, ATROPINUM SULPHURICUM, BOLDO, CARDUUS MAR, CHELIDONIUM MAJ, ECHINACEA, FEL TAURI, HEPAR SUIS, HYDRASTIS, LEPTANDRA, MAG PHOS, NAT PHOS, PODOPH PELT, TARAXACUM | Energetix Corporation | 1d857ae7-ad24-4f3b-8c33-f52851fa1ce6 | 2025-12-17 | Warnings | 03J5ZE7KA5 |
| Diphenoxylate Hydrochloride and Atropine Sulfate | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | Unichem Pharmaceuticals (USA), Inc. | 5117f26c-488f-4ba6-b115-22baf12557f3 | 2025-12-11 | Warnings, Adverse reactions | 03J5ZE7KA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.